4.6 Article

COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors

Journal

EUROPEAN JOURNAL OF EPIDEMIOLOGY
Volume 36, Issue 3, Pages 299-309

Publisher

SPRINGER
DOI: 10.1007/s10654-021-00722-y

Keywords

COVID-19 mortality; SARS-CoV-2; Prospective cohort; UK biobank; Risk factor

Funding

  1. H2020-EXPANSE project (Horizon 2020 grant) [874627]
  2. Cancer Research UK
  3. Population Research Committee Project grant 'Mechanomics' [22184]
  4. MRC Centre for Environment and Health
  5. LongITools project (Horizon 2020 grant) [874739]
  6. MRC Centre for Environment and Health [MR/L01341X/1, MR/S019669/1]
  7. National Institute for Health Research Imperial Biomedical Research Centre
  8. NIHR Health Protection Research Units in Environmental Exposures and Health and Chemical and Radiation Threats and Hazards
  9. BHF Centre for Research Excellence at Imperial College London [RE/18/4/34215]
  10. UK Dementia Research Institute at Imperial and Health Data Research UK (HDR UK)
  11. MRC [MR/L01341X/1, MR/S019669/1] Funding Source: UKRI

Ask authors/readers for more resources

Using data from the UK Biobank cohort, this study investigated factors associated with COVID-19 mortality and found that age, male sex, Black ethnicity, healthcare worker status, smoking, certain comorbidities, and oral steroid use were independently associated with increased risk of COVID-19 death. The study also highlighted the potential contributions of income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use to the risk of COVID-19 mortality.
Most studies of severe/fatal COVID-19 risk have used routine/hospitalisation data without detailed pre-morbid characterisation. Using the community-based UK Biobank cohort, we investigate risk factors for COVID-19 mortality in comparison with non-COVID-19 mortality. We investigated demographic, social (education, income, housing, employment), lifestyle (smoking, drinking, body mass index), biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and environmental (air pollution) data from UK Biobank (N = 473,550) in relation to 459 COVID-19 and 2626 non-COVID-19 deaths to 21 September 2020. We used univariate, multivariable and penalised regression models. Age (OR = 2.76 [2.18-3.49] per S.D. [8.1 years], p = 2.6 x 10(-17)), male sex (OR = 1.47 [1.26-1.73], p = 1.3 x 10(-6)) and Black versus White ethnicity (OR = 1.21 [1.12-1.29], p = 3.0 x 10(-7)) were independently associated with and jointly explanatory of (area under receiver operating characteristic curve, AUC = 0.79) increased risk of COVID-19 mortality. In multivariable regression, alongside demographic covariates, being a healthcare worker, current smoker, having cardiovascular disease, hypertension, diabetes, autoimmune disease, and oral steroid use at enrolment were independently associated with COVID-19 mortality. Penalised regression models selected income, cardiovascular disease, hypertension, diabetes, cystatin C, and oral steroid use as jointly contributing to COVID-19 mortality risk; Black ethnicity, hypertension and oral steroid use contributed to COVID-19 but not non-COVID-19 mortality. Age, male sex and Black ethnicity, as well as comorbidities and oral steroid use at enrolment were associated with increased risk of COVID-19 death. Our results suggest that previously reported associations of COVID-19 mortality with body mass index, low vitamin D, air pollutants, renin-angiotensin-aldosterone system inhibitors may be explained by the aforementioned factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available